2 weeks ago
17
ARTICLE AD BOX
Cancer immunotherapy has reshaped cancer treatment by training the body's immune system to recognize and attack tumors. Drugs known as immune checkpoint inhibitors, which target the PD-1/PD-L1 pathway, have led to long-lasting responses in some patients and fueled optimism about durable cancer control. Yet for most people, these therapies do not deliver the same benefit. Tumors can adapt and develop ways to escape immune detection, limiting the effectiveness of treatment.
English (US) ·